Many consumers are living with chronic or multiple conditions which mean they are in category 1B, which is rolling out now. For this reason they experience a real sense of urgency for them to get the information they need about the vaccine: is it safe for them (and their specific circumstances), how and who can they have this safety conversation with, and when they will be vaccinated.

Read the issues paper >